Ergomed plc (ERGO.L) (LON:ERGO) Hits New 1-Year High at $1,060.00

Ergomed plc (ERGO.L) (LON:ERGO) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 1,060 ($13.85) and last traded at GBX 1,055 ($13.78), with a volume of 23627 shares. The stock had previously closed at GBX 1,040 ($13.59).

The company has a 50-day moving average of GBX 928.89 and a 200-day moving average of GBX 712.35. The company has a debt-to-equity ratio of 48.12, a quick ratio of 1.40 and a current ratio of 1.44. The stock has a market cap of £513.76 million and a price-to-earnings ratio of 84.40.

About Ergomed plc (ERGO.L) (LON:ERGO)

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Outsourcing and Pharmacovigilance.

See Also: Neutral Rating

Receive News & Ratings for Ergomed plc (ERGO.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ergomed plc (ERGO.L) and related companies with MarketBeat.com's FREE daily email newsletter.